Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("American College of Clinical Pharmacology")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 156

  • Page / 7
Export

Selection :

  • and

Defining the maximum tolerated dose: investigator, academic, industry and regulatory perspectivesJournal of clinical pharmacology. 1997, Vol 37, Num 9, pp 767-783, issn 0091-2700Conference Proceedings

American College of Clinical Pharmacology. Annual meetingJournal of clinical pharmacology. 1992, Vol 32, Num 8, pp 733-767, issn 0091-2700Conference Proceedings

Abstracts/13th. Annual meeting of the American College of Clinical Pharmacology, Philadelphia, PA, October 17-19,1984Journal of clinical pharmacology. 1984, Vol 24, Num 8-9, pp 391-427, issn 0091-2700Conference Proceedings

American College of Clinical Pharmacology. Annual meeting programJournal of clinical pharmacology. 1995, Vol 35, Num 9, pp 911-942, issn 0091-2700Conference Proceedings

American College of Clinical Pharmacy, eighth annual meeting, July 19-22, 1987, Austin TX : abstractsDrug intelligence & clinical pharmacy. 1987, Vol 21, 24 p.Conference Proceedings

New directions for clinical pharmacology in the coming millenniumJournal of clinical pharmacology. 2000, Vol 40, Num 9, pp 1025-1067, issn 0091-2700Conference Proceedings

PK/PD Modeling and Simulation: Key Issues and Unresolved Questions in Drup Development and Regulatory Decision Making. SymposiumJournal of clinical pharmacology. 2000, Vol 40, Num 12, pp 1399-1438, issn 0091-2700, 2Conference Proceedings

American College of Clinical Pharmacology. Annual meetingJournal of clinical pharmacology. 1994, Vol 34, Num 10, pp 1003-1033, issn 0091-2700Conference Proceedings

American College of Clinical Pharmacology ACCP. Annual meetingJournal of clinical pharmacology. 1993, Vol 33, Num 10, pp 993-1009, issn 0091-2700Conference Proceedings

From controversy to resolution : bioequivalency of chiral drugsJournal of clinical pharmacology. 1992, Vol 32, Num 10, pp 915-962, issn 0091-2700Conference Paper

American College of Clinical Pharmacology Annual Meeting ProgramJournal of clinical pharmacology. 1996, Vol 36, Num 9, pp 839-866, issn 0091-2700Conference Proceedings

Abstracts/15th. Annual meeting of the American College of Clinical Pharmacology, October 16-17, 1986Journal of clinical pharmacology. 1986, Vol 26, Num 7, pp 541-560, issn 0091-2700Conference Proceedings

5-HT3 receptors : pharmacologic and therapeutic aspectsGYERMEK, L.Journal of clinical pharmacology. 1995, Vol 35, Num 9, pp 845-855, issn 0091-2700Conference Paper

Digitalis and newer inotropic agentsSOMBERG, J. C.Journal of clinical pharmacology. 1985, Vol 25, Num 7, pp 477-559, issn 0091-2700Serial Issue

Advances in pharmacogenetics and pharmacogenomics : 20th-Century advances in drug developmentVESELL, E. S.Journal of clinical pharmacology. 2000, Vol 40, Num 9, pp 930-938, issn 0091-2700Conference Paper

Lessons learned from the past : A guide for the future of Clinical Pharmacology in the 21st century : 20th-Century advances in clinical pharmacologyLATHERS, C. M.Journal of clinical pharmacology. 2000, Vol 40, Num 9, pp 946-966, issn 0091-2700Conference Paper

Interspecies scaling : Role of protein binding in the prediction of clearance from animals to humansMAHMOOD, Iftekhar.Journal of clinical pharmacology. 2000, Vol 40, Num 12, pp 1439-1446, issn 0091-2700, 2Conference Paper

Prevention and treatment of stroke: Where do we stand?GIBALDI, M.Journal of clinical pharmacology. 1997, Vol 37, Num 9, pp 784-790, issn 0091-2700Conference Paper

Crossover trials should not be used to test one treatment against another treatment with a totally different chemical class/mode of actionCLEOPHAS, Ton J.Journal of clinical pharmacology. 2000, Vol 40, Num 12, pp 1503-1508, issn 0091-2700, 2Conference Paper

Optimizing the use of biomarkers, surrogate endpoints, and clinical endpoints for more efficient drug developmentCOLBURN, Wayne A.Journal of clinical pharmacology. 2000, Vol 40, Num 12, pp 1419-1427, issn 0091-2700, 2Conference Paper

Optimizing outcomes in pharmacotherapy (Paris, 28-30 April 2004, abstracts)ACCP-ESCP joint meetingInternational congress on clinical pharmacy. 2004, 199 p.Conference Proceedings

Observation and experiment on the cusp of collaboration : A parallel examination of clinical pharmacology and pharmacoepidemiology : 20th-Century advances in drug developmentLEHMANN, D. F.Journal of clinical pharmacology. 2000, Vol 40, Num 9, pp 939-945, issn 0091-2700Conference Paper

Alternate Medicine Therapies in Traditional Medical Practice. SymposiumJournal of clinical pharmacology. 2000, Vol 40, Num 5, pp 444-467, issn 0091-2700Conference Proceedings

Can fluoroquinolones be considered once-daily therapy ?NEU, H. C.Journal of clinical pharmacology. 1992, Vol 32, Num 8, pp 692-697, issn 0091-2700Conference Paper

Single-dose antibiotic therapy : what has the past taught us ?CARBON, C.Journal of clinical pharmacology. 1992, Vol 32, Num 8, pp 686-691, issn 0091-2700Conference Paper

  • Page / 7